The patient was put on chemotherapy, but then underwent surgical resection following an accident at home.
Patients with diffuse large B-cell lymphoma (DLBCL) most commonly present with masses involving the lymph nodes in the neck, abdomen, or mediastinum, and with symptoms that include weight loss and night sweats.
However, a new case report underscores the variability of the disease. In the case, a patient was found to have a large cystic left retroperitoneal mass that was later diagnosed as DLBCL. The report was published in Cureus.
The World Health Organization has recognized a “relatively rare” subtype of DLBCL in which patients present with a mass in the setting of chronic inflammation or in the growth wall of a preexisting cyst, noted the study authors. Yet, the patient described in the report had neither chronic inflammation nor a preexisting cyst.
“To our knowledge, this is the first case to be reported adding to the already diverse presentation of the disease,” the authors wrote.
The patient was a 53-year-old Black woman with several preexisting health conditions, including chronic iron deficiency anemia, asthma, hypertension, and type 2 diabetes. When she arrived at the hospital, she complained about fatigue, shortness of breath, and pain on the left side of her abdomen. Those symptoms had been going on for a month, but now the patient was also experiencing fever and diarrhea.
Upon examination, her physicians noted a large soft palpable mass in the left upper abdominal quadrant. A subsequent CT scan showed a large mass measuring 21 by 15.5 by 22 cm. It was a predominantly cystic, left retroperitoneal mass with thickened, enhancing walls that was so large it had displaced her left kidney and stomach. The scan also showed multiple enlarged retroperitoneal/para-aortic lymph nodes, the authors said.
After a meeting of a multidisciplinary team, the patient underwent a biopsy, during which surgeons also drained 1.4 L of fluid from the cystic component of the mass. The drainage led to a marked improvement of the patient’s symptoms, the authors said.
The biopsy and cytology confirmed that the patient had large B-cell lymphoma, but because the drainage had relieved her symptoms, her physicians decided to refer the patient for chemotherapy instead of performing surgery to remove the mass.
The patient completed her first cycle of chemotherapy, but then she suffered a fall at home during which she hit the left upper quadrant of her abdomen. A CT scan at the hospital suggested splenic rupture. At that point, the patient underwent surgery to remove both her spleen and the cystic mass. The patient was discharged 7 days later and at the study’s writing, was continuing to undergo outpatient chemotherapy.
The authors said their case shows that, even though rare, hematological cancers should be considered when encountering cystic masses of unknown origin. They said a thorough evaluation with a biopsy is also necessary before surgery is warranted.
“Ultimately, these patients will require chemotherapy which remains the standard of care and surgery may still be required for symptomatic relief for some patients,” they said.
Reference
Genualdi J, Orach T, Gumbs S, Ausqui G, Donaldson B, Ramcharan A. Traumatic rupture of cystic left retroperitoneal mass: an atypical presentation of diffuse large B-cell lymphoma. Cureus. Published online April 18, 2023. doi:10.7759/cureus.37797
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
Emerging Therapies Shine Hope on Small Cell Lung Cancer Treatment
January 28th 2025Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address small cell lung cancer's aggressive nature and resistance to conventional therapy.
Read More
Heath Equity & Access Weekly Roundup: January 27, 2025
January 27th 2025Highlights from last week include President Trump's executive orders, the FDA approval of esketamine nasal spray for depression, mental health access through Medicaid Managed Care, the impact of travel time on surgical outcomes, and life expectancy disparities.
Read More
Dr Kirollos Hanna: An Argument for Outpatient Bispecific Antibody Delivery
January 25th 2025Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.
Read More